Constipation: When to See a Doctor, Causes, and Treatments
Constipation needs prompt medical attention when it comes with bleeding, black stools, persistent or severe abdominal pain, fever, or unexplained weight loss. If symptoms are milder but keep returning or do not improve with self-care, arrange an appointment. The decision depends on your symptoms and usual bowel pattern, not a universal seven-day countdown. [1,2]
Constipation can mean infrequent bowel movements, hard stool, difficult passage or a feeling that you have not emptied completely. You do not need a bowel movement every day to be healthy. The goal is comfortable, predictable passage without persistent straining. [2]
When should you seek care?
| What is happening | What to do |
|---|---|
| Severe or worsening abdominal pain, especially with marked swelling or fever | Seek urgent assessment rather than adding more laxatives. |
| Blood in the stool, rectal bleeding or black stool | Contact a clinician promptly so the source and urgency can be assessed. |
| Constipation with unexplained weight loss or known iron-deficiency anemia | Arrange prompt evaluation; do not assume diet is the whole explanation. |
| Symptoms continue despite self-care, recur often or disrupt daily life | Book an appointment and bring a record of symptoms and treatments tried. |
| A brief change during travel or a change in routine, without the symptoms above | Review meals, fluids, activity and medicines; seek help if it does not settle. |
NIDDK advises immediate medical contact for constipation accompanied by bleeding, constant abdominal pain, fever or unintentional weight loss. [1] New saddle-area numbness, leg weakness or urinary retention with back or leg symptoms is a separate emergency requiring immediate assessment for spinal nerve compression. [3]
Does age determine whether you need a colonoscopy?
A persistent new change in bowel habits deserves evaluation at any age. Turning 50 does not automatically make constipation an emergency or mean that everyone needs a colonoscopy immediately.
For average-risk adults without symptoms, the USPSTF recommends colorectal cancer screening from age 45 through 75. Screening and investigation of symptoms are different decisions. Bleeding, anemia, weight loss, family history and previous screening results influence which tests a clinician chooses. [4]
The AGA explains that colonoscopy is generally unnecessary for constipation alone when screening is current and there are no concerning associated findings. [2]
Why constipation happens
Several contributors can overlap:
- Food and routine: low fiber intake, changes in meals or activity, and repeatedly delaying a bowel movement.
- Medicines: opioids, some antidepressants and anticholinergic drugs, calcium-channel blockers and iron supplements.
- Bowel movement coordination: pelvic floor muscles may not relax properly during passage of stool.
- Other conditions: diabetes, thyroid disease and neurological disorders can contribute in some people. [1,2]
Semaglutide and tirzepatide can also cause constipation. If it starts after a dose change, give the prescriber the drug name, dose and date of the increase. That timing helps distinguish a medication effect from a problem that began earlier. [5,6]
What happens at the appointment?
A useful assessment starts with your usual pattern and what changed. Expect questions about stool consistency, straining, pain, a feeling of blockage, medicines and the response to anything already tried. A physical examination may include a rectal examination when appropriate. Blood or stool tests are selected to investigate the clinical picture; every patient does not need the same thyroid, calcium and metabolic panel. [7]
If symptoms persist, the question becomes whether stool is moving slowly through the colon, whether the pelvic floor is not coordinating properly, or both. In its 2026 update, the AGA advises anorectal manometry with a balloon-expulsion test for most patients with chronic constipation before labeling it refractory. Biofeedback should be completed when a defecatory disorder is identified. [8]
These tests assess function. A colonoscopy looks for disease or structural changes inside the colon and answers a different question.
What treatments work?
Start with a workable daily routine
Build fiber intake gradually through foods you tolerate, with adequate fluid. NIDDK also suggests regular activity and a consistent opportunity to use the bathroom, such as after breakfast. Respond to the urge rather than repeatedly postponing it. A footstool may help you find a more comfortable position. [9]
Track more than frequency. Note whether stool becomes easier to pass and whether straining, discomfort and incomplete emptying improve. That record helps distinguish a partially effective treatment from one that is doing nothing.
Match the medicine to the problem
The 2023 joint AGA-ACG guideline supports these options for adults with chronic idiopathic constipation: [10]
| Treatment | Role in the guideline |
|---|---|
| Psyllium fiber | An initial option, particularly with low dietary fiber intake |
| Polyethylene glycol, or PEG | Strong recommendation for ongoing constipation management |
| Bisacodyl or sodium picosulfate | Strong recommendation for short-term or rescue use |
| Senna, magnesium oxide or lactulose | Options selected according to response and tolerability |
| Linaclotide, plecanatide or prucalopride | Strong recommendations when over-the-counter treatment has not worked |
| Lubiprostone | Another prescription option after inadequate response to over-the-counter treatment |
Prucalopride stimulates motility through the 5-HT4 receptor; it is not a secretagogue. Linaclotide, plecanatide and lubiprostone act through intestinal secretion. Choice depends on the diagnosis, previous treatment, side effects and access. [10]
A person with pelvic floor dyssynergia may need biofeedback to retrain coordination, even when laxatives have softened the stool. Repeatedly adding laxatives does not address every mechanism of constipation. [8]
How treatment changes in specific situations
Opioid use: AGA recommends laxatives first. For constipation that remains troublesome despite laxatives, medicines directed at opioid receptors in the gut, including naldemedine, naloxegol or methylnaltrexone, may be considered. The choice depends on the person's circumstances and prescription instructions. [11]
GLP-1 treatment: review constipation and reduced food or fluid intake with the prescribing team. Wegovy allows delayed dose escalation when a dose is not tolerated; Zepbound dosing also takes tolerability into account. Severe abdominal symptoms need assessment before another dose increase. [5,6]
Pregnancy: diet and fluid changes come first, with a pharmacist, midwife or obstetric clinician helping select a laxative if needed. UKTIS describes bulk-forming agents followed by osmotic options such as lactulose or macrogols. Stimulants can be used when earlier options have not helped; they are not categorically prohibited throughout pregnancy. [12]
Older adults: review medicines, mobility and the practical ability to drink, eat and reach the bathroom. Treatment should be usable in daily life, not just effective on paper. Mineral oil is unsuitable for someone with swallowing difficulty because of aspiration risk. [9,13]
What if nothing seems to help?
Ask which mechanism has been established and whether the treatment trial was adequate. The 2026 AGA update emphasizes checking secondary causes, confirming colonic transit and addressing a defecatory disorder before considering surgery. Surgery is reserved for carefully selected cases of confirmed slow-transit constipation without ongoing pelvic floor dysfunction. [8]
For the next visit, bring a one- or two-week record of bowel movements, stool consistency, pain, medicines and laxative doses. Include what helped, what caused side effects and whether you still felt blocked after the stool became softer. Those details help the clinician choose the next step.
References
- NIDDK. Symptoms and causes of constipation.
- American Gastroenterological Association. Constipation patient information.
- North Bristol NHS Trust. Cauda equina syndrome: symptoms and urgent assessment.
- USPSTF. Colorectal cancer screening recommendation.
- Novo Nordisk. Wegovy prescribing information.
- Eli Lilly. Zepbound prescribing information.
- NIDDK. Diagnosis of constipation.
- Staller K, et al. AGA clinical practice update: evaluation and management of refractory constipation. 2026.
- NIDDK. Treatment for constipation.
- Chang L, et al. AGA-ACG clinical practice guideline: pharmacological management of chronic idiopathic constipation. 2023.
- American Gastroenterological Association. Medical management of opioid-induced constipation.
- UK Teratology Information Service. Laxative treatment during pregnancy.
- MedlinePlus. Mineral oil overdose and aspiration.
